Here we report its design, preclinical development and clinical proof-of-concept study to evaluate the safety, tolerability, PK and pharmacodynamics (PD) of AMG 133
NMDA receptor antagonists depicted in Figure 2, target -
10.1146/annurev-pharmtox-011112-140320 151 MaS.DielschneiderR
Among these, kynurenine (OR = 1.441, 95%CI = 1.0891.906, p-value = 0.018) and 1-stearoyl-GPE (18:0) (OR = 1.263, 95%CI = 1.0291.550, p-value = 0.029) were identified as risk factors for myocarditis, while deoxycarnitine (OR = 0.813, 95%CI = 0.6760.979, p-value = 0.029), 5-acetylamino-6-formylamino-3-methyluracil (OR = 0.864, 95% CI = 0.7750.962, p-value = 0.018), and X-25,422 (OR = 0.721, 95%CI = 0.5870.886, p-value = 0.009) were found to be protective factors
Metformin (a diabetes medicine): Long-term use of metformin can lower Vitamin B12 levels in your body, which may require your doctor to adjust your dose of Folic Acid+l Carnitine+methylcobalamin
One trial evaluated the use of OZEMPIC 2 mg once weekly
